These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7384093)
21. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
22. The antigenic structure of tumour cells as material for a study of tissue differentiation. Olenov JM; Fel VJ J Embryol Exp Morphol; 1968 May; 19(3):299-309. PubMed ID: 4970006 [No Abstract] [Full Text] [Related]
23. Immunological studies after cryosurgical tumor treatment. Schweizer K; Lymberopoulos S; Breining H Minerva Med; 1974 Oct; 65(70):3658. PubMed ID: 4422514 [No Abstract] [Full Text] [Related]
24. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028 [TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part? Montironi R; Galluzzi CM; Diamanti L; Giannulis I; Scarpelli M; De Nictolis M Anticancer Res; 1993; 13(1):129-32. PubMed ID: 8097389 [TBL] [Abstract][Full Text] [Related]
26. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Savage PA; Vosseller K; Kang C; Larimore K; Riedel E; Wojnoonski K; Jungbluth AA; Allison JP Science; 2008 Jan; 319(5860):215-20. PubMed ID: 18187659 [TBL] [Abstract][Full Text] [Related]
32. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. Pinthus JH; Waks T; Schindler DG; Harmelin A; Said JW; Belldegrun A; Ramon J; Eshhar Z Cancer Res; 2000 Dec; 60(23):6563-7. PubMed ID: 11118033 [TBL] [Abstract][Full Text] [Related]
33. [Immunochemical study of the antigens isolated from a gastric adenocarcinoma]. Pavlenko AF; Kurika AV; Moroz SV; Ovodov IuS; Maslova MG Vopr Onkol; 1982; 28(4):14-6. PubMed ID: 6806977 [No Abstract] [Full Text] [Related]
34. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Mickey DD; Stone KR; Wunderli H; Mickey GH; Paulson DF Prog Clin Biol Res; 1980; 37():67-84. PubMed ID: 7384095 [No Abstract] [Full Text] [Related]
36. [The measurement of serum prostatic antigens (gamma-Seminoprotein and beta-Microseminoprotein by radioimmunoassay]. Okabe T; Eto K Igaku Kenkyu; 1982 Oct; 52(3):140-3. PubMed ID: 6190342 [No Abstract] [Full Text] [Related]
37. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741 [TBL] [Abstract][Full Text] [Related]
38. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
39. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648 [TBL] [Abstract][Full Text] [Related]
40. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]